- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00757536
Primary Vitrectomy With Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment
January 24, 2016 updated by: Dr. Christiane I. Falkner-Radler, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Primary Vitrectomy Combined With 360° Endolaser or Encircling Band for Rhegmatogenous Retinal Detachment (V.E.E. Study)
Comparing primary PPV with 360° endolaser photocoagulation with primary PPV with an encircling band for patients with RRDs.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
published
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vienna, Austria, 1030
- The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary rhegmatogenous retinal detachment with or without macula-off detachment phakic or pseudophakic eyes
- Multiple breaks, inferior and posterior located breaks or unclear hole formation
- Proliferative vitreoretinopathy (PVR) stage A and B
Exclusion Criteria:
- Previous retinal detachment surgery
- Giant tears
- PVR stage C
- Age less than 18 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Group 1
|
ppVE and encircling band
|
Active Comparator: Group 2
|
ppVE and endolaser photocoagulation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Retinal redetachment rate
Time Frame: 6 months
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Surgery-related complications, patients' comfort, refractive change, visual acuity and optical coherence tomography.
Time Frame: 6 months
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Christiane I Falkner-Radler, MD, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
- Study Chair: Susanne Binder, MD, The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2006
Primary Completion (Actual)
December 1, 2012
Study Completion (Actual)
December 1, 2012
Study Registration Dates
First Submitted
September 21, 2008
First Submitted That Met QC Criteria
September 22, 2008
First Posted (Estimate)
September 23, 2008
Study Record Updates
Last Update Posted (Estimate)
January 26, 2016
Last Update Submitted That Met QC Criteria
January 24, 2016
Last Verified
January 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FR-3-CI-2008
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rhegmatogenous Retinal Detachment
-
Ain Shams UniversityNot yet recruitingRhegmatogenous Retinal Detachment
-
The S.N. Fyodorov Eye Microsurgery State InstitutionUnknownRhegmatogenous Retinal DetachmentRussian Federation
-
Meir Medical CenterUnknownRhegmatogenous Retinal DetachmentIsrael
-
University of Campinas, BrazilCompletedRhegmatogenous Retinal Detachment
-
Samsung Medical CenterCompletedRhegmatogenous Retinal Detachment
-
Universidade Federal do ParanáCompletedRhegmatogenous Retinal Detachment
-
Singapore National Eye CentreCompleted
-
Massachusetts Eye and Ear InfirmaryRecruiting
-
AllerganCompletedRhegmatogenous Macula-off Retinal DetachmentUnited Kingdom, Korea, Republic of, Israel, India, United States, Philippines
-
Tanta UniversityCompletedRhegmatogenous Retinal Detachment of Both Eyes (Diagnosis)Egypt
Clinical Trials on Encircling Band
-
Hospital Clinic of BarcelonaCompletedDrug-refractory Paroxysmal Atrial FibrillationSpain
-
NYU Langone HealthHope FoundationCompleted
-
Umeå UniversityCompletedPostoperative Nausea and Vomiting | Craniotomy | AcupressureSweden
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Tanta UniversityUnknown
-
Saglik Bilimleri Universitesi Gulhane Tip FakultesiUnknownPostoperative Complications | Postoperative Nausea and Vomiting
-
Minia UniversityNot yet recruitingObesity, Morbid
-
National Taiwan University HospitalChina Medical University, TaiwanCompletedMigraine; StatusTaiwan
-
Medical University of South CarolinaCompleted
-
Ethicon Endo-SurgeryCompletedObesity, MorbidUnited States